Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma
about
Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosisCirculating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Human Infectious DiseasesMicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinomaDiagnostic and therapeutic management of hepatocellular carcinomaMicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapyCirculating microRNAs are not eliminated by hemodialysisMicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.Hepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs?Differential expression and functions of microRNAs in liver transplantation and potential use as non-invasive biomarkers.miR-21 inhibitor suppresses proliferation and migration of nasopharyngeal carcinoma cells through down-regulation of BCL2 expression.Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.Complex interactions between microRNAs and hepatitis B/C viruses.Serum microRNA is a promising biomarker for osteogenesis imperfectaActivation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN geneHepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway.Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.Correlation of microRNA-16, microRNA-21 and microRNA-101 expression with cyclooxygenase-2 expression and angiogenic factors in cirrhotic and noncirrhotic human hepatocellular carcinomaMicroRNA and hepatitis C virus--challenges in investigation and translation: a review of the literature.The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.MicroRNAs: Role in Hepatitis C Virus pathogenesisMicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas.miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan.Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis.Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis.MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis.Differential MIR-21 expression in plasma from mesenteric versus peripheral veins: an observational study of disease-free survival in surgically resected colon cancer patients.Brief Report: Coordinated Modulation of Circulating miR-21 in HIV, HIV-Associated Pulmonary Arterial Hypertension, and HIV/Hepatitis C Virus Coinfection.Method for microRNA isolation from clinical serum samplesCirculating miRNA profile in HCV infected serum: novel insight into pathogenesis.Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression.MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers.Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinomaSerum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinomaHepatitis C virus infection, microRNA and liver disease progressionmicroRNAs in liver disease: from diagnostics to therapeutics.Targeting microRNAs in pancreatic cancer: microplayers in the big game.RNA viruses and microRNAs: challenging discoveries for the 21st century.Use of Serum MicroRNAs as Biomarker for Hepatobiliary Diseases in Dogs.MicroRNAs in Liver Disease: Bench to Bedside.Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells.
P2860
Q21560965-57F65585-9485-484A-B663-966C3FC07D32Q26738323-3D78208E-3F73-477B-9256-5A71357A3A04Q26751392-800B3A8C-B9D1-4BD5-B2E9-F10F70E5118BQ26999043-F061859F-0CF2-4C39-AC5D-370A2ACF102CQ27015778-3166980E-A2AC-4107-8A21-93EE8E4F2B1CQ28728683-56371B50-7F50-436B-993C-7891A1798C35Q30439971-933A329A-E88D-49D0-ADA4-CE1F3841B73FQ30456435-DB717AAE-9CAD-4078-861C-6DF96DC734B9Q33649970-689C8273-01C4-4AA9-BD98-1A77DA0AE3A5Q33898669-2BC49CF2-CF4F-4BCE-9BCD-D1A6C5F8C245Q34252178-AD7CE7BD-FB91-4C2A-A4AB-0F70BE4BBB20Q34302987-4D1EBF22-37E7-4A16-AE52-6EAC970D8926Q34377839-A592B088-DB3A-4311-B3F1-86F89A5F7E34Q34443746-395829BC-83F6-4028-B50E-173D6DCF7CEEQ34505974-AB913866-30B4-4CFF-844C-457D0E2C8FD8Q34729935-4F21C935-49A8-4145-8D14-5D7A0B0C9D4BQ35156115-C7DB09F8-76AB-4368-8E1F-7AC93D465AC6Q35202304-31B324F4-FE6D-4B9E-A15A-57E7393C8431Q35561701-CC5DCFDB-7451-4088-A641-0CAD16C8713EQ35606627-C5168C4D-0BE7-45BE-A4C3-1F3B5EC20F31Q35752063-A0FF4DF3-C744-48B4-B4A3-B9E0A3B45223Q35819563-6E8D42EF-FA34-40E4-97C5-5F5DCB3AD38DQ35840874-9C0B8E8D-6F0D-4466-95B9-8C46623DF7B8Q35843599-CD89C932-BD93-4E11-AFEE-693ACA9BF5C9Q36146616-CF100308-52C6-47BA-A62E-A54A77164E9FQ36152800-EF90762C-3D23-43A2-96D0-2C8128776642Q36175085-4A8B2464-2623-44CB-9336-149D1E4774D2Q36349449-86E7A9A7-56A8-41D3-A081-8FA7BD53D877Q36737114-7D8AB4E9-4279-4998-AF9E-F2C7DFC9DBDBQ36875670-6F9C473E-7BDE-4752-8A1E-611A1424D3BAQ36906199-B1F5F6CF-73EF-46EB-957B-593AAB2A8AF3Q37031706-CC9DE593-8D6B-40A8-B403-6D2626A5C753Q37196131-487CD492-25AD-4570-BCE7-F735D9B7A325Q37196517-1FACEA1D-B4A2-4BA2-BFBA-40AD4D31F43CQ37246198-F557EE59-0A98-4326-B320-7E7A827BDE6EQ37325758-B421197E-22DD-4D57-B957-8F7819737309Q37346014-35A551B6-D2B8-4BF7-930A-62AF120A1867Q37422764-24286D15-FCB2-49CB-A5E9-69996528551AQ37613598-2FE868E2-AB0C-439B-9CD4-07B3D3C71CC6Q37619724-76385F3B-425B-4374-9858-8F8C6079D753
P2860
Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Serum microRNA-21 as marker fo ...... thout hepatocellular carcinoma
@ast
Serum microRNA-21 as marker fo ...... thout hepatocellular carcinoma
@en
Serum microRNA-21 as marker fo ...... thout hepatocellular carcinoma
@nl
type
label
Serum microRNA-21 as marker fo ...... thout hepatocellular carcinoma
@ast
Serum microRNA-21 as marker fo ...... thout hepatocellular carcinoma
@en
Serum microRNA-21 as marker fo ...... thout hepatocellular carcinoma
@nl
prefLabel
Serum microRNA-21 as marker fo ...... thout hepatocellular carcinoma
@ast
Serum microRNA-21 as marker fo ...... thout hepatocellular carcinoma
@en
Serum microRNA-21 as marker fo ...... thout hepatocellular carcinoma
@nl
P2093
P2860
P50
P1433
P1476
Serum microRNA-21 as marker fo ...... thout hepatocellular carcinoma
@en
P2093
Andreas Polta
Bernd Kronenberger
Christoph Sarrazin
Jan Peveling-Oberhag
Jörg Haupenthal
Jörg Trojan
Martin Welker
Michael von Wagner
Mireen Friedrich-Rust
Nicole Forestier
P2860
P304
P356
10.1371/JOURNAL.PONE.0026971
P407
P577
2011-10-31T00:00:00Z